How does fluticasone work in the body?
Fluticasone is a corticosteroid (anti-inflammatory steroid). After dosing, it enters cells in the body and binds to the intracellular glucocorticoid receptor. The drug-receptor complex then changes gene expression in a way that reduces the production of inflammatory mediators (such as cytokines and other signaling proteins), which lowers inflammation and immune activity at the treatment site. That is what drives fluticasone’s anti-inflammatory effect.
What does that mean for conditions like allergic rhinitis and asthma?
In allergic rhinitis and asthma, fluticasone’s reduced inflammatory signaling helps decrease swelling, mucus production, and recruitment of inflammatory cells in the airways or nasal passages. Less inflammation typically means fewer symptoms such as congestion, runny nose, sneezing (nasal use), or cough and airway irritation/wheeze (inhaled use).
Why don’t steroid nasal sprays and inhalers act immediately?
Fluticasone’s effects rely on changes in gene expression and downstream mediator production, so symptom improvement usually takes time rather than happening instantly. As inflammation gradually decreases over days, patients typically see more consistent relief with continued use.
What fluticasone forms are there, and does the mechanism differ?
The core mechanism is the same across fluticasone products because it is still a glucocorticoid. What changes is the route and targeted tissue:
- Intranasal fluticasone targets nasal mucosa for allergic rhinitis.
- Inhaled fluticasone targets lung airways for asthma or COPD (depending on formulation/approval).
Systemic corticosteroid effects are generally lower with well-targeted local use, but the underlying receptor-mediated anti-inflammatory action remains the same.